@MitchellOsak@srg444@jamiecampbell@401RIA 💯 Especially if MJ is used as nothing more than a US political football. It’s simple, US MJ is not investable until it’s legalized. 280e taxes away profits from illegal MJ. The CSA (S3) highly regulates medical MJ, which MSO’s cannot meet, let alone export. S3 regs take years.
@cupofcoffeecap Also, as soon as $OGI gets EU GMP approval for their Moncton facility and/or acquires a EU GMP facility, they will be better positioned than GTI with global reach, profitability, cash flow, no net debt, better product mix, NASDAQ listing, growth & good management. Trades < book.
@jfberke SIX figures + lost salary OMG! OK, can’t resist: What’s the payback period, opportunity cost & ROI on a MBA from a top private university? And finally, how about the dispersion. Ultimately, it’s about developing your lifetime competence and character, regardless of compensation.
@jfberke 💯 1996 vs today MBA: 1996 more theoretical, no professors of practice; more team projects less case studies; less quantitative, more qualitative critical thinking. Professors actually available and small class sizes. Today, they use math to explain human behavior. Doesn’t work.
@markemerritt@CultivatedNews FYI, my 30 years of M&A experience tells me that, if no friendly deal gets done within the 105 days, everyone friendly will walk and ACB price will crater. ACB is arrogant enough to believe they can go it alone. That is very unlikely. The saga continues….. IMHO
@jfberke I wouldn’t expect that, both he and OGI are way too smart to get in a bidding war. They already torched $. But I don’t believe CURA will ever get it. So, at some point, after the dust settles, it doesn’t mean they are not interested, at the appropriate price, of course. M&A 101.
@canna_smith@markemerritt@CultivatedNews My MJ investment thesis: US is FUBAR for 12-18 months. Canadian MJ is alpha. Specifically, core positions are OGI, VFF and CRON. I own ACB, but prefer it goes to OGI or CRON, NOT CURA for competitive reasons. I also use options on core positions to manage/enhance returns.
@markemerritt@mgorenst One final thought. I wonder if Mike just tipped his hand with respect to CRON buying ACB. Why would he buy it if he believes it’s easier and cheaper to convert an existing facility? CURA wants ACB exactly because it enhances his EU GMP supply chain. Green washing is done.
@markemerritt@CultivatedNews OGI has been trying to convert a portion of their Moncton facility to EU GMP since mid 2024. They repeatedly promised every quarter since 2025 it would happen soon. Still not done. Data verification must demonstrate consistent quality of product over time. Thus, they need ACB.
@markemerritt@CultivatedNews BTW, this dilemma, which Mike gets wrong, is exactly why people are interested in ACB. It is cheaper and more time efficient to buy an existing EU GMP certified facility because someone has already done the hard work. It’s not just the facility, it’s the data verification aspect.
@bmrntvs2pk@ModneyRullen NO, its financials and business model are much better. VFF has EU GMP, global, legal, growing, profitable, no net debt and cash flow positive. GLAS had none of these.
@JDerevyanny@Wake_Setter@SECGov Me neither. I think they have an IQ test in place: if your IQ is above 60, you’re not invited, no matter how much doobie you might want to sample.
419 Followers 931 FollowingNavigating the volatility of bull and bear cycles, we shun fleeting trends to focus on fundamental principles and genuine value. #BTC
730 Followers 2K FollowingDeveloper, systems engineer, quantitative trading, futures, equities, and options. Following business news, micro and macro economics. #MSOGang
1K Followers 419 FollowingI advise stakeholders, regulators, and municipal leaders on the macro & the micro of cannabis industry mechanics.
https://t.co/o1oxn02Fay
318 Followers 1K Followinghost of High Spirits, inquisitor, life enthusiast, optimist and pragmatist, longtime cannabis entrepreneur, advisor, MBA. CEO @ https://t.co/nTZ7ofGdDA
98K Followers 62 FollowingGlobal Markets Investor is a financial research platform covering global markets and economies. Founded by a Wall Street equity and macro research professional.
2K Followers 1K FollowingFractional Leader in the Global Cannabis Industry | Adviser | Subscribe for Free to my Blog, the Cannabis Management Review, at https://t.co/7ut17tv2jO
454 Followers 543 FollowingDirector of IR at @Organigram_Inc | Canada's #1 LP | Nothing posted relates to $OGI unless indicated | Nothing here is investment advice
1K Followers 763 FollowingFounder of @SanityGroupEU, ex-BCG, ex-CEO at Movinga, Co-Founder @theiconicau, digital thinker, entrepreneur and co-founder of @Berliner_Berg #cannabis 💚
2K Followers 385 FollowingOur lives begin to end the day we become silent about things that matter
I give opinion, NOT investment advice
Feelings aren't facts
12K Followers 958 FollowingSubscribe to newsletter: https://t.co/cgZkdPZw0I CEO of Mindset Capital. Author of The Hard Break: The Case for a 24/6 Lifestyle.
94 Followers 51 FollowingResearching companies, industries, while working in capital markets. Focused on asymmetric opportunities and disciplined thinking.
584 Followers 9 FollowingI write a lot about the intersection of cannabis, administrative law, & the Constitution. Marijuana Herald contributor.
Disclaimer: not legal advice.
4.9M Followers 3 FollowingWatcher Guru gives you unparalleled, unbiased coverage of all-things crypto & finance in real-time | Posts Are Not Financial Advice | @BTCPrice
195 Followers 3 FollowingHigher Exchanges, hosted by @jesseredmond and @morganpaxhia, is the number one independent cannabis investing show. We deliver actionable insights you can use.
37K Followers 733 FollowingBettering lives through cannabis. We’re a consumer-centric global leader built on cultivation excellence, quality, trust, & discipline.
Must be 19+ to follow
11K Followers 49 FollowingCronos is a global cannabis company, scaling leading consumer goods products. Spinach®, PEACE NATURALS®, LIT™, Lord Jones® & COG. Following confirms you're 19+.
18K Followers 342 FollowingOne of the leading cannabis companies in Canada and Germany, the world's two largest federally legal markets. $OGI. Must be 19+ to follow.
2.0M Followers 221 FollowingBreaking news and analysis on global markets
Live updates: https://t.co/5fCN0iMdOA
Sign up for the new Markets Daily newsletter: https://t.co/jPvsdu1EIP
1.2M Followers 1K FollowingStart your morning with Joe Kernen, Becky Quick, and Andrew Ross Sorkin - Monday through Friday from 6-9a ET on CNBC and streaming on CNBC+.
1.1M Followers 1K FollowingRene M Kern Prof of Prac at Wharton. Allianz Advisor. Gramercy Chair. Chair of UnderArmour Board. Former Pimco CEO/co-CIO and President of Queens' Col Cambridge
10K Followers 356 FollowingThe Official Account For IgniteIt's Cannabis, Hemp, CBD & Psychedelics Related News.
IgniteIt now operates the Cannabis business formerly owned by Benzinga.
86K Followers 1 FollowingYour top source for updates on the most important marijuana & cannabis news. Federal, state, international, business, science & culture. Editor: @tomangell
2K Followers 873 FollowingAppellate lawyer obsessed with administrative law. Knows a lot abt drug policy and even more abt federal controlled substance law.
9K Followers 695 FollowingCB1 Capital is an investment manager / advisor that specializes in cannabinoid-based wellness solutions, products and therapies.
2K Followers 47 FollowingManaging Partner at Zuanic & Associates. Renowned equity research analyst. Check us out at https://t.co/yCjSpeWZPo. No financial advice here.